Foyston, Gordon, & Payne Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$13.4M |
| 2 |
Tidewater
TDW
|
+$9.77M |
| 3 |
Mattel
MAT
|
+$9.66M |
| 4 |
Conagra Brands
CAG
|
+$6.65M |
| 5 |
State Street
STT
|
+$5.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$22M |
| 2 |
BHI
Baker Hughes
BHI
|
+$18.4M |
| 3 |
Newell Brands
NWL
|
+$8.15M |
| 4 |
PPL
PPL Corp
PPL
|
+$7.03M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Technology | 16.93% |
| 3 | Financials | 15.18% |
| 4 | Energy | 10.88% |
| 5 | Consumer Staples | 9.84% |
Similar funds
Foyston, Gordon, & Payne's Q1 2014 Portfolio in Review
As of Q1 2014, Foyston, Gordon, & Payne held 92 positions worth $812M, up 0.74% from $806M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Foyston, Gordon, & Payne withdrew a net $26.9M in Q1 2014, closing 7 positions and reducing 31 holdings. Its most notable exit was Newell Brands, an estimated $8.15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.
Against the trend, Foyston, Gordon, & Payne opened a new position in iShares Russell 2000 ETF worth $13.5M.
- Foyston, Gordon, & Payne's largest Q1 2014 buy was iShares Russell 2000 ETF: 116,200 shares worth $13.5M.
- Foyston, Gordon, & Payne added most to Tidewater in Q1 2014, an estimated $9.77M increase.
- Foyston, Gordon, & Payne's biggest Q1 2014 reduction was Teva Pharmaceuticals, cutting an estimated $22M.
- Foyston, Gordon, & Payne fully exited Newell Brands in Q1 2014, selling an estimated $8.15M.
- Foyston, Gordon, & Payne's ten largest holdings make up 32% of its $812M portfolio in Q1 2014.
- Foyston, Gordon, & Payne opened 3 new positions and closed 7 in Q1 2014.
- Foyston, Gordon, & Payne's portfolio value rose 0.74% quarter-over-quarter to $812M.
Based on Foyston, Gordon, & Payne's 13F filing for Q1 2014, filed 14 May 2014.